Cargando…

Cyclin-Dependent Kinase 5 Inhibitor Butyrolactone I Elicits a Partial Agonist Activity of Peroxisome Proliferator-Activated Receptor γ

Adiponectin is an adipocyte-derived cytokine having an insulin-sensitizing activity. During the phenotypic screening of secondary metabolites derived from the marine fungus Aspergillus terreus, a poly cyclin-dependent kinase (CDK) inhibitor butyrolactone I affecting CDK1 and CDK5 was discovered as a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ahn, Sungjin, Jang, Dong Man, Park, Sung Chul, An, Seungchan, Shin, Jongheon, Han, Byung Woo, Noh, Minsoo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7072624/ https://www.ncbi.nlm.nih.gov/pubmed/32054125 http://dx.doi.org/10.3390/biom10020275

Ejemplares similares

Macakurzin C Derivatives as a Novel Pharmacophore for Pan-Peroxisome Proliferator-Activated Receptor Modulator
por: Ko, Hyejin, et al.
Publicado: (2023)

Protonation of γ‐Butyrolactone and γ‐Butyrolactam
por: Beck, Stefanie, et al.
Publicado: (2020)

Synthesis of novel phytol-derived γ-butyrolactones and evaluation of their biological activity
por: Gliszczyńska, Anna, et al.
Publicado: (2021)

A Review of the Pharmacological Activities and Recent Synthetic Advances of γ-Butyrolactones
por: Hur, Joonseong, et al.
Publicado: (2021)

The Agonists of Peroxisome Proliferator-Activated Receptor-γ for Liver Fibrosis
por: Li, Jingjing, et al.
Publicado: (2021)

Medium Chain Fatty Acids Are Selective Peroxisome Proliferator Activated Receptor (PPAR) γ Activators and Pan-PPAR Partial Agonists
por: Liberato, Marcelo Vizoná, et al.
Publicado: (2012)

Characterisation of a natural variant of the γ-butyrolactone signalling receptor
por: Gottelt, Marco, et al.
Publicado: (2012)

In vivo voltammetric studies on release mechanisms for cocaine with γ-butyrolactone
por: Broderick, Patricia A.
Publicado: (1991)

Suppression of Rat Oral Carcinogenesis by Agonists of Peroxisome Proliferator Activated Receptor γ
por: McCormick, David L., et al.
Publicado: (2015)

Synergy between peroxisome proliferator‐activated receptor γ agonist and radiotherapy in cancer
por: Huang, Guodong, et al.
Publicado: (2018)

CMHX008, a Novel Peroxisome Proliferator-Activated Receptor γ Partial Agonist, Enhances Insulin Sensitivity In Vitro and In Vivo
por: Ming, Yue, et al.
Publicado: (2014)

Peroxisome proliferator-activated receptor-γ agonists and diabetes: Current evidence and future perspectives
por: Chiarelli, Francesco, et al.
Publicado: (2008)

Antitumor action of the peroxisome proliferator-activated receptor-γ agonist rosiglitazone in hepatocellular carcinoma
por: BO, QI-FU, et al.
Publicado: (2015)

Peroxisome Proliferator-Activated Receptors (PPAR)γ Agonists as Master Modulators of Tumor Tissue
por: Heudobler, Daniel, et al.
Publicado: (2018)

New α-Methylene-γ-Butyrolactone Derivatives as Potential Fungicidal Agents: Design, Synthesis and Antifungal Activities
por: Wu, Yongling, et al.
Publicado: (2016)

Enantioconvergent Synthesis of Functionalized γ-Butyrolactones via (3 + 2)-Annulation
por: Goodman, C. Guy, et al.
Publicado: (2014)

Unravelling the γ-butyrolactone network in Streptomyces coelicolor by computational ensemble modelling
por: Tsigkinopoulou, Areti, et al.
Publicado: (2020)

High pressure as a novel tool for the cationic ROP of γ-butyrolactone
por: Bernat, Roksana, et al.
Publicado: (2021)

Expression of peroxisome proliferator-activated receptor (PPAR)γ in gastric cancer and inhibitory effects of PPARγ agonists
por: Sato, H, et al.
Publicado: (2000)

Effects of Sulfonylureas on Peroxisome Proliferator-Activated Receptor γ Activity and on Glucose Uptake by Thiazolidinediones
por: Lee, Kyeong Won, et al.
Publicado: (2011)

Simultaneous Quantification of γ-Hydroxybutyrate, γ-Butyrolactone, and 1,4-Butanediol in Four Kinds of Beverages
por: Jin, Shaoming, et al.
Publicado: (2020)

Facile access to chiral γ-butyrolactones via rhodium-catalysed asymmetric hydrogenation of γ-butenolides and γ-hydroxybutenolides
por: Zhou, Yuxuan, et al.
Publicado: (2023)

Different skeletal effects of the peroxisome proliferator activated receptor (PPAR)α agonist fenofibrate and the PPARγ agonist pioglitazone
por: Syversen, Unni, et al.
Publicado: (2009)

Natural product agonists of peroxisome proliferator-activated receptor gamma (PPARγ): a review
por: Wang, Limei, et al.
Publicado: (2014)

Pioglitazone, a Peroxisome Proliferator-Activated Receptor γ Agonist, Suppresses Rat Prostate Carcinogenesis
por: Suzuki, Shugo, et al.
Publicado: (2016)

Peroxisome proliferator-activated receptor γ agonist suppresses mast cell maturation and induces apoptosis
por: Zhang, Yu, et al.
Publicado: (2017)

Correction to “Enantioconvergent Synthesis of Functionalized γ-Butyrolactones via (3 + 2)-Annulation”
por: Goodman, C. Guy, et al.
Publicado: (2015)

An efficient enantioselective approach to multifunctionalized γ-butyrolactone: concise synthesis of (+)-nephrosteranic acid
por: Gehlawat, Anju, et al.
Publicado: (2020)

Phenalenones from a Marine-Derived Fungus Penicillium sp.
por: Park, Sung Chul, et al.
Publicado: (2019)

Peroxisome proliferator-activated receptor γ agonist effect on rheumatoid arthritis: a randomized controlled trial
por: Ormseth, Michelle J, et al.
Publicado: (2013)

Lack of the effect of lobeglitazone, a peroxisome proliferator-activated receptor-γ agonist, on the pharmacokinetics and pharmacodynamics of warfarin
por: Jung, Jin Ah, et al.
Publicado: (2015)

Renal-Protective Effects of the Peroxisome Proliferator-Activated Receptor-γ Agonist Pioglitazone in ob/ob Mice
por: Li, Ying, et al.
Publicado: (2019)

Diallyl Biphenyl-Type Neolignans Have a Pharmacophore of PPARα/γ Dual Modulators
por: Han, Yujia, et al.
Publicado: (2020)

Design and validation of a PCR screen for γ-butyrolactone-like regulatory systems in Streptomyces
por: Waschulin, Valentin, et al.
Publicado: (2023)

Polyacetylenes from Notopterygium incisum–New Selective Partial Agonists of Peroxisome Proliferator-Activated Receptor-Gamma
por: Atanasov, Atanas G., et al.
Publicado: (2013)

Repurposing of substances with lactone moiety for the treatment of γ-Hydroxybutyric acid and γ-Butyrolactone intoxication through modulating paraoxonase and PPARγ
por: Fateh, Sepand Tehrani, et al.
Publicado: (2022)

Effects of peroxisome proliferator activated receptors (PPAR)-γ and -α agonists on cochlear protection from oxidative stress
por: Sekulic-Jablanovic, Marijana, et al.
Publicado: (2017)

Peroxisome proliferator activated receptor-γ agonist pioglitazone improves vascular and metabolic dysfunction in systemic lupus erythematosus
por: Hasni, Sarfaraz, et al.
Publicado: (2022)

The isolation, Characterization and Preclinical Studies of Metal Complex of Thespesia populnea for the Potential Peroxisome Proliferator-activated Receptors-γ Agonist Activity
por: Phanse, Mohini Ashok, et al.
Publicado: (2015)

To Probe Full and Partial Activation of Human Peroxisome Proliferator-Activated Receptors by Pan-Agonist Chiglitazar Using Molecular Dynamics Simulations
por: Sullivan, Holli-Joi, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_28og2ooaueqclgr71i48q803ke